Hy Hybrid

Cheese


Overview:

Named for its sharply sour aroma, Cheese is an indica-dominant hybrid from the U.K. that has achieved widespread popularity for its unique flavor and consistent potency. With origins that stretch back to the late 1980s, Cheese is said to descend from a Skunk #1 phenotype whose pungent aroma made it stand out. Breeders like Big Buddha Seeds later introduced Afghani indica genetics to increase Cheese’s trichome production and yields. The resulting hybrid is now well-known for its relaxed, happy effects that gently ease you into a blissful state of mind.

Strain Attributes:

Effects

Euphoric

Happy

Hungry

Relaxed

Uplifted

Euphoric

Happy

Hungry

Relaxed

Uplifted

Medical Uses

Depression

Headaches

Insomnia

Pain

Stress

Depression

Headaches

Insomnia

Pain

Stress

Negatives

Dizzy

Dry Eyes

Dry Mouth

Headache

Paranoid

Dizzy

Dry Eyes

Dry Mouth

Headache

Paranoid


Rate this Strain!

SPONSORS


FROM OUR BLOG


Opinion

15 Million People Will Drive High This Month Says AAA Survey

Do people use cannabis and get in car accidents? Sure.  Do they also look down at their phone or get in accidents while texting? You bet.  Do people drink alcohol and get in a higher rate of accident? Yes. The problem isn’t some new cannabis laws creating zombie drivers, it is just we need to teach proper safety use for using machinery and driving cars for all distractions and substances.
Opinion

Is Marijuana Legalization a Red or a Blue Issue in a Politically Charged World?

While it’s good to finally see that politicians are standing up to legalize cannabis with proposed bills like The MORE Act and the likes; there is something we are beginning to see clearly. Cannabis is no longer really a left or right issue. There are plenty of bipartisan sponsored bills floating around in Congress and the Senate that it simply doesn’t seem that Trump’s narrative holds ground.
Opinion

Can I Travel with My CBD? Learn the Loopholes in Legalization

Until the agency is able to answer all its questions regarding the safety of CBD, the popular cannabinoid will continue to be scrutinized by authorities. However, pressure to speed up the FDA’s regulation timeline has been mounting. On October 16, after a few months’ delay, the agency released its latest report on its current findings as well as a number of answers to the many questions posed by consumers, including ones on why the agency has yet to approve CBD products.